AR002021A1 - Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades yprocedimiento para la obtencion de dichos compuestos. - Google Patents
Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades yprocedimiento para la obtencion de dichos compuestos.Info
- Publication number
- AR002021A1 AR002021A1 ARP960101024A AR10102496A AR002021A1 AR 002021 A1 AR002021 A1 AR 002021A1 AR P960101024 A ARP960101024 A AR P960101024A AR 10102496 A AR10102496 A AR 10102496A AR 002021 A1 AR002021 A1 AR 002021A1
- Authority
- AR
- Argentina
- Prior art keywords
- antagonists
- compounds
- trascinic
- benzacepine
- vasopresin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Abstract
Antagonistas de vasoprasina de benzocepina tricíclicos de la fórmula (I), donde Y es -(CH2)n- en la que n es un entero de 0 a 1, y A-B es una porción-(CH2)m-NR3- o -NR3-(CH2)m- en la cual m es un entero de 1 a 2; y el anillo Z representa: (1) fenilo substituido o no con 1 ó 2 alquilo, halógeno, amino,alcoxi o alquilamino; (2) un anillo heterocíclico (insaturado) aromático de 5 ó 6 miembros con hasta 2 heteroátomos de N, O y S siendo siempre al menos uno, N.D, E y F son nitrógeno, o carbono substituidos o nó con halógeno, hidroxi, -COCl3, -COCF3, alcoxicarbonilo, alquilo sustituido o nó por OH, alcoxi, aminoheterociclos del N de 5 y 6 miembros saturados o insaturados. R3 es arilcarbonilo o piridilcarbonilo donde la partecíclica puede estar sustituidapor compuestos heterocíclicos y no heterocíclicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/373,125 US5521173A (en) | 1995-01-17 | 1995-01-17 | Tricyclic benzazepine vasopressin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002021A1 true AR002021A1 (es) | 1998-01-07 |
Family
ID=23471074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960101024A AR002021A1 (es) | 1995-01-17 | 1996-01-15 | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades yprocedimiento para la obtencion de dichos compuestos. |
Country Status (24)
Country | Link |
---|---|
US (2) | US5521173A (es) |
EP (1) | EP0805813B1 (es) |
JP (2) | JP4156664B2 (es) |
CN (1) | CN1052725C (es) |
AR (1) | AR002021A1 (es) |
AT (1) | ATE217625T1 (es) |
AU (1) | AU707881B2 (es) |
BR (1) | BR9607177A (es) |
CA (1) | CA2210708C (es) |
CZ (1) | CZ224797A3 (es) |
DE (1) | DE69621225T2 (es) |
DK (1) | DK0805813T3 (es) |
EA (1) | EA000056B1 (es) |
ES (1) | ES2175066T3 (es) |
HK (1) | HK1003891A1 (es) |
HU (1) | HUP9702459A3 (es) |
IL (1) | IL116774A (es) |
MX (1) | MX9705414A (es) |
NZ (1) | NZ301198A (es) |
PT (1) | PT805813E (es) |
TW (1) | TW472056B (es) |
UA (1) | UA48960C2 (es) |
WO (1) | WO1996022292A1 (es) |
ZA (1) | ZA96303B (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736540A (en) * | 1993-07-29 | 1998-04-07 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5700796A (en) * | 1995-01-17 | 1997-12-23 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5753648A (en) * | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5880122A (en) * | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
CA2285343A1 (en) | 1997-03-31 | 1998-10-08 | Wakamoto Pharmaceutical Co., Ltd. | Biphenyl derivatives and medicinal compositions |
US6511974B1 (en) | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
BR9811585A (pt) * | 1997-07-30 | 2000-09-26 | American Home Prod | Agonistas de vasopressinas tricìclicas |
US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
WO2000043398A2 (en) * | 1999-01-19 | 2000-07-27 | Ortho-Mcneil Pharmaceutical, Inc. | Tricyclic benzodiazepines as vasopressin receptor antagonists |
EP1149103A1 (en) * | 1999-02-04 | 2001-10-31 | American Home Products Corporation | Thienylbenzoylbenzazepines as vasopressin agonists |
US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6344451B1 (en) | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
CA2385971A1 (en) * | 1999-09-27 | 2001-04-05 | American Cyanamid Company | Vasopressin agonist formulation and process |
AU2002256685B2 (en) * | 2001-03-20 | 2008-01-24 | Merck Serono Sa | Pyrrolidine ester derivatives with oxytocin modulating acitvity |
US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
CA2443870A1 (en) * | 2001-04-12 | 2002-10-24 | Wyeth | Cyclohexylphenyl vasopressin agonists |
US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
EP1381370B1 (en) * | 2001-04-12 | 2007-03-07 | Wyeth | N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists |
US7109193B2 (en) * | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
US6900200B2 (en) * | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
US6903087B2 (en) * | 2001-04-12 | 2005-06-07 | Wyeth | Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
ATE362934T1 (de) * | 2001-10-29 | 2007-06-15 | Ortho Mcneil Pharm Inc | Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten |
US7119088B2 (en) * | 2003-02-19 | 2006-10-10 | Pfizer Inc. | Triazole compounds useful in therapy |
CA2660799C (en) * | 2006-08-14 | 2013-03-19 | Council Of Scientific & Industrial Research | Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
WO2009152133A1 (en) * | 2008-06-10 | 2009-12-17 | Abbott Laboratories | Novel tricyclic compounds |
CA2741018A1 (en) | 2008-11-13 | 2010-05-20 | F. Hoffmann-La Roche Ag | Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes |
MX2011005119A (es) | 2008-11-18 | 2011-05-30 | Hoffmann La Roche | Alquilciclohexileteres de dihidrotetraazabenzoazulenos. |
NZ592076A (en) | 2008-11-28 | 2012-06-29 | Hoffmann La Roche | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists |
AR079234A1 (es) | 2009-12-01 | 2012-01-04 | Abbott Lab | Derivados heterociclicos condensados nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar afecciones oncologicas, del sistema nervioso y/o del sistema inmune. |
NZ599938A (en) | 2009-12-01 | 2014-08-29 | Abbvie Inc | Novel tricyclic compounds |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
AU2011261164A1 (en) | 2010-06-01 | 2012-12-13 | The University Of Queensland | Haematopoietic-prostaglandin D2 synthase inhibitors |
CN103288829A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓-5-酮的方法 |
WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
PT2970205T (pt) | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CN116270646A (zh) | 2015-10-16 | 2023-06-23 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CA3103995A1 (en) | 2018-07-26 | 2020-01-30 | Sumitomo Dainippon Pharma Oncology, Inc. | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3763183A (en) * | 1972-07-10 | 1973-10-02 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines |
US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
DE69009785T2 (de) * | 1989-02-10 | 1994-11-03 | Otsuka Pharma Co Ltd | Carbostyrilderivate. |
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
KR0167349B1 (ko) * | 1989-10-20 | 1999-02-18 | 오스카 아끼히꼬 | 벤조헤테로 고리 화합물 |
US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
TW199153B (es) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
TW198715B (es) * | 1991-04-19 | 1993-01-21 | Dtsuka Seiyaku Kk | |
US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
EP0533243B1 (en) * | 1991-09-16 | 1997-12-17 | Merck & Co. Inc. | Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives |
EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
TW250481B (es) * | 1992-08-20 | 1995-07-01 | Otsuka Pharma Co Ltd | |
WO1994012476A1 (en) * | 1992-11-25 | 1994-06-09 | Yamanouchi Pharmaceutical Co., Ltd. | Benzanilide derivative |
AU5692094A (en) * | 1992-12-21 | 1994-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor |
AU6219994A (en) * | 1993-03-11 | 1994-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Compound with vasopressin antagonism |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
-
1995
- 1995-01-17 US US08/373,125 patent/US5521173A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 AR ARP960101024A patent/AR002021A1/es unknown
- 1996-01-15 ZA ZA96303A patent/ZA96303B/xx unknown
- 1996-01-16 TW TW085100471A patent/TW472056B/zh not_active IP Right Cessation
- 1996-01-16 ES ES96902143T patent/ES2175066T3/es not_active Expired - Lifetime
- 1996-01-16 NZ NZ301198A patent/NZ301198A/xx unknown
- 1996-01-16 CN CN96192570A patent/CN1052725C/zh not_active Expired - Fee Related
- 1996-01-16 BR BR9607177A patent/BR9607177A/pt not_active IP Right Cessation
- 1996-01-16 EA EA199700118A patent/EA000056B1/ru not_active IP Right Cessation
- 1996-01-16 DK DK96902143T patent/DK0805813T3/da active
- 1996-01-16 IL IL11677496A patent/IL116774A/xx not_active IP Right Cessation
- 1996-01-16 UA UA97084248A patent/UA48960C2/uk unknown
- 1996-01-16 HU HU9702459A patent/HUP9702459A3/hu unknown
- 1996-01-16 AU AU46566/96A patent/AU707881B2/en not_active Ceased
- 1996-01-16 DE DE69621225T patent/DE69621225T2/de not_active Expired - Fee Related
- 1996-01-16 CA CA002210708A patent/CA2210708C/en not_active Expired - Fee Related
- 1996-01-16 AT AT96902143T patent/ATE217625T1/de not_active IP Right Cessation
- 1996-01-16 EP EP96902143A patent/EP0805813B1/en not_active Expired - Lifetime
- 1996-01-16 JP JP52234496A patent/JP4156664B2/ja not_active Expired - Fee Related
- 1996-01-16 WO PCT/US1996/000515 patent/WO1996022292A1/en not_active Application Discontinuation
- 1996-01-16 PT PT96902143T patent/PT805813E/pt unknown
- 1996-01-16 MX MX9705414A patent/MX9705414A/es not_active IP Right Cessation
- 1996-01-16 CZ CZ972247A patent/CZ224797A3/cs unknown
- 1996-05-23 US US08/652,198 patent/US5780471A/en not_active Expired - Lifetime
-
1998
- 1998-04-16 HK HK98103196A patent/HK1003891A1/xx not_active IP Right Cessation
-
2007
- 2007-11-21 JP JP2007301897A patent/JP2008069176A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2175066T3 (es) | 2002-11-16 |
DE69621225D1 (de) | 2002-06-20 |
EP0805813B1 (en) | 2002-05-15 |
WO1996022292A1 (en) | 1996-07-25 |
EA199700118A1 (ru) | 1997-12-30 |
US5521173A (en) | 1996-05-28 |
HK1003891A1 (en) | 1998-11-13 |
UA48960C2 (uk) | 2002-09-16 |
EP0805813A1 (en) | 1997-11-12 |
CA2210708A1 (en) | 1996-07-25 |
ZA96303B (en) | 1997-07-15 |
TW472056B (en) | 2002-01-11 |
ATE217625T1 (de) | 2002-06-15 |
JPH11500424A (ja) | 1999-01-12 |
HUP9702459A3 (en) | 2000-08-28 |
NZ301198A (en) | 1999-08-30 |
US5780471A (en) | 1998-07-14 |
IL116774A0 (en) | 1996-05-14 |
CN1178532A (zh) | 1998-04-08 |
CA2210708C (en) | 2005-05-24 |
JP2008069176A (ja) | 2008-03-27 |
EA000056B1 (ru) | 1998-04-30 |
CN1052725C (zh) | 2000-05-24 |
AU707881B2 (en) | 1999-07-22 |
DK0805813T3 (da) | 2002-08-05 |
DE69621225T2 (de) | 2002-11-14 |
JP4156664B2 (ja) | 2008-09-24 |
BR9607177A (pt) | 1997-11-11 |
PT805813E (pt) | 2002-10-31 |
CZ224797A3 (cs) | 1998-03-18 |
MX9705414A (es) | 1997-11-29 |
HUP9702459A2 (hu) | 1998-05-28 |
IL116774A (en) | 2000-12-06 |
AU4656696A (en) | 1996-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002021A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades yprocedimiento para la obtencion de dichos compuestos. | |
AR002022A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, uso de los mismos para la manufactura de un medicamento y un procedimiento para preparar dichos compuestos. | |
HRP20031098B1 (en) | Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
PE20080708A1 (es) | Compuestos 2-pirrolidincarboxamida sustituidos como inhibidores de la proteasa que activa el canal respiratorio | |
AR021055A1 (es) | Derivados de pirazolopiridina | |
CY1108714T1 (el) | Ανταγωνιστες υποδοχεα cgrp | |
AR038818A1 (es) | Compuesto de piperidina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
ES2112332T3 (es) | Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico. | |
MXPA03011522A (es) | Derivados de naftil indol sustiduidos como inhibidores del tipo 1 del inhibidor del activador del plasmingeno. | |
AR068695A2 (es) | Uso de un compuesto de tiazol que comprende un derivado de tiazol para la fabricacion de un medicamento para la prevencion y el tratamiento de en-fermedades causadas por la produccion anormal de citocinas y/o la acele-racion de la adhesion de neutrofilos y/o la produccion anormal de tnf- alfa | |
CL2004001167A1 (es) | Compuestos derivados de tiazolidindionas; procedimiento de elaboracion: composicion farmaceutica que los contiene; y su uso en el tratamiento de la diabetes. | |
DE60222775D1 (de) | Analoga als antitumorale verbindungen | |
ATE359786T1 (de) | Camptothecin derivate | |
MX9405324A (es) | Aductos de epoxidos de amina impedida como estabilizantes. | |
CO5590916A2 (es) | Dicetopiperacinas sustituidas como antagonistas de oxitocina | |
ATE338047T1 (de) | Stickstoffbasierte camptothecin-derivate | |
AR013462A1 (es) | Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos | |
ECSP034504A (es) | Derivados de acido oxazolil-arilpropionico y su uso como agonista ppar | |
AR041339A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
AR017072A1 (es) | Compuestos derivados de pirrolopirrolona como inhibidores de elastasa neutrofilica, uso de dichos compuestos, metodos de tratamiento, procesos depreparacion e intermediarios utiles para su produccion | |
MX9400253A (es) | Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2059931T3 (es) | Procedimiento para el tratamiento de la hipertrofia e hiperplasia cardiaca asi como vascular. | |
DK178388D0 (da) | Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho-(2,3-b)furan og af 2,3,6,7,8,9-hexahydro-5h-benzocyklohepta-(2,3-b)furan, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem | |
BR0110517A (pt) | Derivados de diaminopirazol e agentes de tingimento contendo estes compostos |